(Q28583746)

31 January 2017

title

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease (English)

1 reference

chronic renal insufficiency

31 January 2017

1 reference

1 reference

secondary hyperparathyroidism

inferred from title

1 reference

H. Galitzer

1

1 reference

31 January 2017

I. Z. Ben-Dov

series ordinal

2

1 reference

31 January 2017

Justin Silver

series ordinal

3

1 reference

31 January 2017

Tally Naveh-Many

series ordinal

4

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

31 January 2017

1 reference

31 January 2017

volume

77

1 reference

31 January 2017

issue

3

1 reference

31 January 2017

page(s)

211–218

1 reference

Regulation of fibroblast growth factor-23 signaling by klotho

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Klotho converts canonical FGF receptor into a specific receptor for FGF23

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

FGF-23 in patients with end-stage renal disease on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Regulation of fibroblast growth factor-23 in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Mechanisms of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Reaccumulation of thyroglobulin and colloid in rat and mouse thyroid follicles during intense thyrotropin stimulation. A clue to the pathogenesis of colloid goiters

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Animal model of adenine-induced chronic renal failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.464

7 January 2021

Identifiers

1 reference

Dimensions Publication ID

31 January 2017

1040492799

0 references

1 reference